Listed by the USPTO as MARLEN, TAMMIE K
Tech Center 3700 • Art Units: 3700 3762 3766 3792 3796
This examiner grants 75% of resolved cases
MARLEN, TAMMIE K is assigned to tech center 3700 and art unit 3700. The profile covers 818 resolved cases, with a 75.3% allowance rate and a 20.8% interview lift. The median time to allowance is 1374 days, indicating that successful prosecution can still involve extended pendency.
Listed company activity includes Biotronik SE & Co. KG, Boston Scientific Corporation, and Oura Health Oy. The listed firms are BUCHANAN INGERSOLL & ROONEY PC, ARENTFOX SCHIFF LLP, and BOTOS CHURCHILL IP LAW LLP-ABIO. Applicants in this docket may find interview practice relevant when developing prosecution strategy.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18668615 | IMPLANTABLE MEDICAL DEVICE INCLUDING ELECTRODES FORMED THEREIN | Non-Final OA | Cardiac Pacemakers, Inc. |
| 18294493 | PARAMETER VARIATIONS IN NEURAL STIMULATION | Final Rejection | Cala Health, Inc. |
| 17609160 | DEVICES AND METHODS FOR TREATING TINNITUS USING ELECTRICAL STIMULATION | Final Rejection | Mayo Foundation for Medical Education and Research |
| 18447067 | WEARABLE RING DEVICE FOR ON-THE-GO CHARGING | Non-Final OA | Oura Health Oy |
| 18155467 | WEARABLE DEVICES | Final Rejection | Oura Health Oy |
| 18681160 | Sensing System for Sensing Biological Signals Externally on a Patient | Non-Final OA | BIOTRONIK SE & Co. KG |
| 18292113 | Braid-Supported Helical Leads for Implantable Electrode Leads | Final Rejection | BIOTRONIK SE & Co. KG |
| 18263728 | 5G Implant with Predetection and/or with a 5G Modem | Non-Final OA | BIOTRONIK SE & CO. KG |
| 18287094 | Closed-Loop Neuromodulation for the Treatment of Affective Neuropsychiatric Disorders | Final Rejection | The Regents of the University of California |
| 19053650 | DUAL LUMEN SHEATH FOR ARTERIAL ACCESS | Non-Final OA | ABIOMED, Inc. |
| 18807096 | PURGE-FREE MINIATURE ROTARY PUMP | Non-Final OA | ABIOMED, Inc. |
| 18682343 | DEVICES WITH INTEGRATED CONCAVE COILS | Non-Final OA | Cochlear Limited |
| 18461957 | IN-BAND TELEMETRY FOR DEVICE LONGEVITY | Final Rejection | Medtronic, Inc. |
| 18548621 | SKIN-ADHERENT, ULTRA-STRETCHABLE, AND CONFORMAL WEARABLE ELECTROCARDIOGRAPHIC DEVICE AND FABRICATION METHOD | Final Rejection | The Hong Kong University of Science and Technology |
| 18646637 | METHODS AND DEVICES FOR TREATING PELVIC CONDITIONS | Non-Final OA | HOLOGIC, INC. |
| 17791523 | WEARABLE CHRONIC MONITORING SYSTEMS, METHODS, AND DEVICES | Final Rejection | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA |
| 18326407 | HERMETIC FEEDTHROUGH ASSEMBLY AND ASSOCIATED METHODS | Final Rejection | Pacesetter, Inc. |
| 19171993 | NEUROSTIMULATION SYSTEMS USING SENSE AND OUTCOMES DATA | Non-Final OA | Boston Scientific Neuromodulation Corporation |
| 18540469 | CONNECTOR CONTACT FOR ELECTRICAL STIMULATION SYSTEM | Final Rejection | Boston Scientific Neuromodulation Corporation |
| 19098758 | ALERT BUTTON TRAINING SYSTEM FOR A WEARABLE MEDICAL DEVICE AND METHOD THEREOF | Non-Final OA | WEST AFFUM HOLDINGS DAC |
| 18063464 | COMPRESSION GARMENT ASSEMBLY FOR APPLYING TTFIELDS AND METHODS OF PRODUCTION AND USE THEREOF | Final Rejection | Novocure GmbH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy75.3% of resolved applications examined by Tammie K Marlen were allowed (818 resolved cases), compared with 66.1% across Art Unit 3700 over the last five years.
This examiner's interview lift is +20.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Tammie K Marlen took 1,374 days on average from filing to allowance.
Tammie K Marlen examines applications in Art Unit 3700 in Tech Center 3700 (Medical Devices & Mechanical Engineering).